Wishing everyone a happy holiday season! We're extremely happy for what we've accomplished so far and we're looking forward to 2022, to embark into new adventures and keep growing alongside our investors, partners & portfolio companies. We wish you plenty of joy and happiness.

We are excited to announce SpliceBio €50M series A to continue to build its next generation gene therapy platform. ASABYS PARTNERS entered the company in 2020 and will keep supporting it to take it to the next level. @Sylvain_Sachot asabys.com/splicebio-rais…

Big thanks to the European Investment Fund for their constant support and to our strategic partner Alantra and our anchor investor Banc Sabadell for believing in this team and in the importance of healthcare research and innovation. expansion.com/catalunya/2022…

Pleased to announce Sabadell Asabys' follow-on investment in Sidekick Health's $55M Series B to support its future growth! Together with Wellington Partners frumtak and Novator Partners. #digitalhealth asabys.com/digital-therap…

📈 “We’ve observed growth in funds investing in the sector,” Laoura Ntziourou, EIF. 💬 Engaging panel led by @jmboure on how start-ups with massive growth potential can raise enough money in Europe. Wellington Partners VitaDX International European Investment Fund ASABYS PARTNERS Maite Malet #BitsHealth

Great Bits & Pretzels Healthtech conference in Munich sharing industry insights with investors, corporates and startups EIT Health European Investment Fund Wellington Partners #bitsandpretzels #HealthTech

Definitely interesting, specially for founders #fundraising #vc techcrunch.com/2022/09/22/sci…

The Asabys team wishes you a Merry Christmas and a Happy 2023! Looking forward to living the new adventures of 2023, which we hope will be full of joy and success. Let's Rock 2023! ASABYS PARTNERS

There's a new healthtech fund in town... as ASABYS PARTNERS announces a €100m first close — targeting €200m by the end of the year. Sifted finds out what health and biotech segments the firm wants to invest in: sifted.eu/articles/asaby…

Looking forward to it @T_Silberzahn !!

Participating in today’s Women’s Health Investor Summit in the New York Stock Exchange, discussing trends, challenges and opportunities in the space. Thanks Supernode Ventures NYSE 🏛 LippeTaylor McDermott Will & Schulte

Yesterday VCs, CVCs, foundations, endowments, pharma, and others, came together for the 'Women's Health Investor Summit' at the NYSE 🏛 to talk about the state of women's health and how to accelerate innovation, research and access. Thanks Supernode Ventures

Many insights shared today during the #DigitalHealthForum23 held by McDermott Will & Schulte in #NYC specially around data privacy, business self-sustainability, care efficiency, prevention and diagnostic needs, within others. Maite Malet

Inspiradoras sesiones del Grupo Harvard en Boston y NY, compartiendo nuestra visión sobre el presente y futuro de Barcelona. Me quedo con las muchas C's definidas: capital, cooperación, cultura, conectividad… Manel Pérez Josep Ll. Sanfeliu IESE Business School lavanguardia.com/economia/20230…

Last day at LSI European Summit with Maite Malet from ASABYS PARTNERS at the “Emerging VC Leaders” panel with great investors Speedinvest nina.capital Philips @epidarex. Thanks LSI - Life Science Intelligence™

Attended "2023 Prix Galien USA Forum and Gala" last week in NYC. Thank you Elsa Rive Boukadoum and the rest of the The Galien Foundation members for organizing such an amazing event. Congratulations to portfolio co' Xtreme Results for being nominated as Best Digital Health Solution. #PrixGalien

We are attending #JPM2024 in San Francisco this week, looking forward to connect! Josep Ll. Sanfeliu Clara Campàs 🎗 Maite Malet

It was an amazing week! #JPM2024

Happy #InternationalWomensDay! We are incredibly proud of our female colleagues, portfolio entrepreneurs and executives. #InspireInclusion diverse teams advance faster, and better. #internationalwomensday2024 #IWD2024 #InvestInWomen #womeninscience #WomenInVC #inspireinclusion

After a successful Asabys Investors' Day, we are proud to announce the oversubscription of our Fund II Sabadell Asabys (Banco Sabadell), reaching €160M. Let's see if we can get to the €200M hard-cap! Very proud to have been selected by Fond-ICO (ICO) as one of this year's